ABT: Abbott Laboratories - Summary | Jitta

Abbott Laboratories

NYSE:ABT

End of day
Dec 14, 2018
Price
$70.76
Loss Chance
51.1%
4.25
Updated 2018Q3
last month
Nov 05, 2018
JITTA SCORE
64.42%Above Jitta Line
Jitta Ranking
138 / 795
United States
?
NASDAQ, NYSE
1,977 / 4,758
Grow your money with Jitta Ranking. See details.
HISTORICAL JITTA SCORE
Jitta Factors
Growth Opportunity (23)
Recent Business Performance (68)
Financial Strength (30)
Return to Shareholders (25)
Competitive Advantage (42)
Jitta Signs
Revenue and Earning
201220132014201520162017
Revenue12.0812.7013.4313.8614.1615.71
EPS3.111.321.291.661.250.21
Earning decline from 2014-2017
Operating Margin
20132014201520162017
Operating Margin (%)11.1414.2614.5215.7110.73
Declined
Debt Level
20132014201520162017
Net Profit (mill.)2,043.521,940.402,449.621,844.64357.51
Long Term Debt (mill.)3,388.003,393.005,871.0020,681.0027,210.00
Very High Long Term Debt
Recent Business Performance
Earning per ShareQ1Q2Q3Q4
20180.280.410.34-
20170.120.160.32-0.28
20160.860.95-0.240.54
Earning decline 80.62% in the last year
Key Stats
Jitta Score
Jitta Line
4.25
64.42%
2.44
0.48%
Healthcare Equipment
COMPANY DESCRIPTION
Abbott Laboratories discovers, develops, manufactures, and sells health care products worldwide. The company’s Established Pharmaceutical Products segment offers branded generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency; irritable bowel syndrome or biliary spasm; intrahepatic cholestasis or depressive symptoms; gynecological disorders; hormone replacement therapy; dyslipidemia; hypertension; hypothyroidism; Ménière's disease and vestibular vertigo; pain, fever, and inflammation; migraines; and anti-infective clarithromycin, as well as provides influenza vaccine and products that regulate physiological rhythm of the colon. Its Diagnostic Products segment offers core laboratory systems in the areas of immunoassay, clinical chemistry, hematology, and transfusion; molecular diagnostics systems that automates the extraction, purification, and preparation of DNA and RNA from patient samples, as well as detects and measures infectious agents; cartridges for blood analysis; benchtop systems and rapid tests in the areas of infectious diseases; molecular point-of-care test systems for influenza A and B, RSV, and strep A; cardiometabolic test systems; drug and alcohol test systems, as well as remote patient monitoring and consumer self-test systems; and informatics and automation solutions for use in laboratories. The company’s Nutritional Products segment provides pediatric and adult nutritional products. Its Cardiovascular and Neuromodulation Products segment offers rhythm management, electrophysiology, heart failure, vascular, and structural heart devices for the treatment of cardiovascular diseases, as well as neuromodulation devices for the management of chronic pain and movement disorders. The company also provides blood and flash glucose monitoring systems, including test strips, sensors, data management decision software, and accessories for people with diabetes. The company was founded in 1888 and is headquartered in Abbott Park, Illinois.